UBS lowered the firm’s price target on Visteon (VC) to $130 from $142 and keeps a Buy rating on the shares. The firm is relatively cautious heading into earnings, the analyst tells investors in a research note.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VC: